Garitaonandia; Ibon

Patent Applications and Registrations

Patent applications and USPTO patent grants for Garitaonandia; Ibon.The latest application filed is for "use of neural cells derived from human pluripotent stem cells for the treatment of neurodegenerative diseases".

Company Profile

1.6.6

Garitaonandia; Ibon - Carlsbad CA
Garitaonandia; Ibon - San Diego CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of neural cells derived from human pluripotent stem cells for the treatment of neurodegenerative diseases Grant 11,007,232 - Kern , et al. May 18, 2	2021-05-18
Method of prevention of neurological diseases Grant 10,258,632 - Gonzalez , et al.	2019-04-16
Use Of Neural Cells Derived From Human Pluripotent Stem Cells For The Treatment Of Neurodegenerative Diseases App 20180339001 - Kern; Russell A. ; et al.	2018-11-29
Use Of Neural Cells Derived From Human Pluripotent Stem Cells For The Treatment Of Neurodegenerative Diseases App 20180339000 - Kern; Russell A. ; et al.	2018-11-29
Use of neural cells derived from human pluripotent stem cells for the treatment of neurodegenerative diseases Grant 10,039,794 - Kern , et al. August 7, 2	2018-08-07
Derivation of neural stem cells and dopaminergic neurons from human pluripotent stem cells Grant 9,926,529 - Gonzalez , et al. March 27, 2	2018-03-27
Method of Prevention of Neurological Diseases App 20150094289 - Gonzalez; Rudolfo ; et al.	2015-04-02
Derivation of Neural Stem Cells and Dopaminergic Neurons from Human Pluripotent Stem Cells App 20150087541 - Gonzalez; Rodolfo ; et al.	2015-03-26
Use Of Neural Cells Derived From Human Pluripotent Stem Cells For The Treatment Of Neurodegenerative Diseases App 20140314721 - Semechkin; Ruslan ; et al.	2014-10-23
High throughput assays for inhibitors and activators of PAQR receptors Grant 8,809,001 - Lyons , et al. August 19, 2	2014-08-19
High Throughput Assays for Inhibitors and Activators of PAQR Receptors App 20100261178 - Lyons; Thomas ; et al.	2010-10-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.